GMF(SZ:002551) Sou Hu Cai Jing·2026-01-25 19:06Group 1 - The core viewpoint of the news is that Shangrong Medical (002551) is expected to report significant losses for the year 2025, with projected net profit losses ranging from 1.2 billion to 1.7 billion yuan [1][3] - On January 23, 2026, Shangrong Medical's stock closed at 3.91 yuan, reflecting a 0.26% increase, with a turnover rate of 1.47% and a trading volume of 90,000 shares, amounting to a transaction value of 35.177 million yuan [1] - The company reported a net inflow of 4.2705 million yuan from major funds on January 23, while retail investors experienced a net outflow of 0.8129 million yuan [1][3] Group 2 - The company announced that the expected loss for the year 2025, attributable to shareholders, is projected to be between 1.2 billion and 1.7 billion yuan, with a non-recurring net profit loss estimated between 1.361926 billion and 1.861926 billion yuan [1][3] - The anticipated losses are primarily attributed to a decrease in hospital engineering projects, lower-than-expected receivables leading to increased bad debt provisions, a decline in revenue from medical consumables exports due to international conditions, rising costs, and increased foreign exchange losses [1][3]